Amputation among patients with diabetes mellitus - increased risk of neuropathy and diabetic ulcers in taller patients

Patients with diabetes mellitus are at risk of leg ulcers. These eventually become infected, respond poorly to treatment and often require amputation of the foot or part of the leg.

Several factors combine to increase the chances of a leg ulcer developing. One of these is the loss of nerve conduction to the lower extremity so that patient's don't feel symptoms of a developing ulcer (pain) and don't recognize its early presence. It is also known that such neuropathy (declining nerve function) occurs most frequently and earliest in longer nerves, such as those going to the legs.

In this study, the authors looked at rates of amputation among close to 100 000 patients with diabetes mellitus and found that height was a strong predictor of amputation. In the whole study population, every 10-cm increase in height was associated with a 16% increase in risk of amputation. In the subgroup of patients for whom data on fasting plasma glucose levels and dyslipidemia were available, the risk of amputation was even greater (79% relative increase in risk of amputation. This finding was independent of other factors such as the adequacy of diabetes control.

These findings, particularly that the risk of amputation was present even among patients who had good control of their diabetes and other risk factors, should prompt clinicians and patients to be alert to the increased risk of neuropathy and diabetic ulcers in taller patients.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage